Uncategorized

Survival for UK cancer patients is lower than in much of Europe, according to a new report. The Association of the British Pharmaceutical Industry (ABPI) reports that on average, the UK is 8th lowest in Europe for cancer patients being alive 5 years after a cancer diagnosis. The UK is also behind the European average for survival for 9 of the most common kinds of cancer. Emma Greenwood, Cancer Research UK’s director of policy, said that if survival is to improve, the UK needs to get better at diagnosing and treating cancer earlier. The report also states that the UK spends relatively less on cancer than the European average. Dr Richard Torbett, executive director of the ABPI, claims: “[T]hat comparatively lower levels of UK investment in cancer is having on the quality of care available to British patients.”

See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-07-19-uk-cancer-survival-trails-europe